Hematopoietic Stem Cell Transplantation (HSCT) Market

Hematopoietic Stem Cell Transplantation (HSCT) Market Companies Pharmaceuticals & Conditioning Therapies Novartis In 2025, Novartis stands as a major player in the HSCT market with estimated revenue contributions around $2.35 billion from HSCT-related therapies. The company is renowned for its CAR‑T therapy, Kymriah, which is utilized in treating certain blood cancers. Beyond CAR‑T, Novartis provides […]